Status:
UNKNOWN
Central Analgesic Drugs for the Treatment of Chronic Pain
Lead Sponsor:
University of Parma
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Brief Summary
Chronic pain is defined as pain that persists after healing of the wound that caused it, and can occur even in the absence of any obvious pathological trigger. In our country, there is a growing inter...
Detailed Description
Chronic pain is defined as pain that persists after healing of the wound that caused it, and can occur even in the absence of any obvious pathological trigger. In our country, there is a growing inter...
Eligibility Criteria
Inclusion
- Males and females over the age of 18 years
- Chronic neuropathic and / or nociceptive and / or mixed pain, whereby clinicians considers necessary to start opioid therapy
- Signed informed consent
Exclusion
- Males and females aged under 18 years
- Patients already receiving opioid analgesic drugs or drugs of the class MOR-NRI.
- Taking abuse drugs or alcohol abuse
- Patients with contraindications to the use of central analgesic drugs
- Patients who refuse participation
- Prior cognitive impairment or mental retardation
- Severe immunodeficiency (WBC \<4,000)
- Severe renal impairment (serum creatinine \> 2g/dl or Creatinine clearance \<30 ml / h)
- Hepatic impairment (Cholinesterase \<2.000UI or INR\> 2)
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2017
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02223442
Start Date
September 1 2014
End Date
February 1 2017
Last Update
August 22 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.